Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation

Virchows Archiv

Volumn 451, Issue 3, 2007, Pages 691-699

  Kudo, Naoko ^a   Ogose, Akira ^a   Hotta, Tetsuo ^a   Kawashima, Hiroyuki ^a   Gu, Wenguang ^a   Umezu, Hajime ^b   Toyama, Tsuyoshi ^c   Endo, Naoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c SRL INC   (Japan)

Author keywords

Characterization; Chondrosarcoma; Dedifferentiated chondrosarcoma; New cell line; Osteoblastic differentiation

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN P53;

ADULT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL DIFFERENTIATION; CHONDROSARCOMA; FEMUR; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LUNG CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PHOSPHORYLATION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; WESTERN BLOTTING;

ADULT; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CHONDROSARCOMA; CHROMOSOME ABERRATIONS; FEMORAL NEOPLASMS; GENES, P53; HUMANS; KARYOTYPING; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MUTATION; NEOPLASM TRANSPLANTATION; OSTEOBLASTS; PLEURAL EFFUSION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548301888     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0426-3     Document Type: Article

References (63)

1. Aigner T (2002) Towards a new understanding and classification of chondrogenic neoplasias of the skeleton-biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441:219-230
2. Aigner T, Unni KK (1999) Is dedifferentiated chondrosarcoma a "de-differentiated" chondrosarcoma? J Pathol 189:445-447
3. Basciani S, Mariani S, Arizzi M, Brama M, Ricci A, Betsholtz C, Bondjers C, Ricci G, Catizone A, Galdieri M, Spera G, Gnessi L (2004) Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice. Biol Reprod 70:168-177
4. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA (2003) Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36:7-16
5. Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ (2004) Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst 96:46-55
6. Bovee JV, Cleton-Jansen AM, Kuipers-Dijkshoorn NJ, van den Broek LJ, Taminiau AH, Cornelisse CJ, Hogendoorn PC (1999) Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer 26:237-246
7. Bovee JV, Cleton-Jansen AM, Rosenberg C, Taminiau AH, Cornelisse CJ, Hogendoorn PC (1999) Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189:454-462
8. Bovee JV, Sciot R, Cin PD, Debiec-Rychter M, Zelderen-Bhola SL, Cornelisse CJ, Hogendoorn PC (2001) Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol 10:228-235
9. Bridge JA, DeBoer J, Travis J, Johansson SL, Elmberger G, Noel SM, Neff JR (1994) Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol 144:215-220
10. Bruns J, Fiedler W, Werner M, Delling G (2005) Dedifferentiated chondrosarcoma-a fatal disease. J Cancer Res Clin Oncol 131:333-339
11. Capanna R, Bertoni F, Bettelli G, Picci P, Bacchini P, Present D, Giunti A, Campanacci M (1988) Dedifferentiated chondrosarcoma. J Bone Jt Surg Am 70:60-69
12. Casorzo L, Chiecchio L, Pisacane A, Fumero S, Canavese F, Torchio B, Risio M (2003) Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet 144:61-64
13. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD (1995) p53 expression and DNA ploidy of cartilage lesions. Human Pathol 26:620-624
14. Dahlin DC, Beabout JW (1971) Dedifferentiation of low-grade chondrosarcomas. Cancer 28:461-466
15. Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH, Scully SP (2004) Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Jt Surg Am 86-A:2412-2418
16. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH, Benhaim P (2003) Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Jt Surg Br 85:740-747
17. Frassica FJ, Unni KK, Beabout JW, Sim FH (1986) Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases. J Bone Jt Surg Am 68:1197-1205
18. Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, Vincent A, Muller-Hermelink HK, Marx A (1999) A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. J Mol Diagn 1:23-31
19. Gisselsson D, Palsson E, Hoglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl N (2002) Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer 33:133-140
20. Grote HJ, Schneider-Stock R, Neumann W, Roessner A (2000) Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Virchows Arch 436:494-497
21. Haberler C, Gelpi E, Marosi C, Rossler K, Birner P, Budka H, Hainfellner JA (2006) Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. J Neuro-oncol 76:105-109
22. Hayami T, Shukunami C, Mitsui K, Endo N, Tokunaga K, Kondo J, Takahashi HE, Hiraki Y (1999) Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett 458:436-440
23. Holtkamp N, Okuducu AF, Mucha J, Afanasieva A, Hartmann C, Atallah I, Estevez-Schwarz L, Mawrin C, Friedrich RE, Mautner VF, Deimling A (2006) Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity. Carcinogenesis 27:664-671
24. Hotta T, Motoyama T, Watanabe H (1992) Three human osteosarcoma cell lines exhibiting different phenotypic expressions. Acta Pathol Jpn 42:595-603
25. Huang B, Ning Y, Lamb AN, Sandlin CJ, Jamehdor M, Ried T, Bartley J (1998) Identification of an unusual marker chromosome by spectral karyotyping. Am J Med Genet 80:368-372
26. Jaworski RC (1984) Dedifferentiated chondrosarcoma. An ultrastructural study. Cancer 53:2674-2678
27. Kahn LB (1976) Chondrosarcoma with dedifferentiated foci. A comparative and ultrastructural study. Cancer 37:1365-1375
28. Knuutila S, Armengol G, Bjorkqvist AM, el-Rifai W, Larramendy ML, Monni O, Szymanska J (1998) Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. Cancer Genet Cytogenet 100:25-30
29. Kudawara I, Araki N, Myoui A, Kato Y, Uchida A, Yoshikawa H (2004) New cell lines with chondrocytic phenotypes from human chondrosarcoma. Virchows Arch 444:577-586
30. Kunisada T, Miyazaki M, Mihara K, Gao C, Kawai A, Inoue H, Namba M (1998) A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77:854-859
31. Lagonigro MS, Tamborini E, Negri T, Staurengo S, Dagrada GP, Miselli F, Gabanti E, Greco A, Casali PG, Carbone A, Pierotti MA, Pilotti S (2006) PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol 208:615-623
32. Lau CC, Harris CP, Lu XY, Perlaky L, Gogineni S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos AG, Meyers PA, Healy JH, Gorlick R, Rao PH (2004) Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 39:11-21
33. Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E, Valle J, Bohling T, Tarkkanen M, Rydholm A, Akerman M, Bauer HC, Anttila JP, Elomaa I, Knuutila S (1999) Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas. Human Pathol 30:1247-1253
34. Mandahl N, Gustafson P, Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HC, Larsson O (2002) Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer 33:188-200
35. McCarthy EF, Dorfman HD (1982) Chondrosarcoma of bone with dedifferentiation: a study of eighteen cases. Human Pathol 13:36-40
36. McFarland GB Jr, McKinley LM, Reed RJ (1977) Dedifferentiation of low grade chondrosarcomas. Clin Orthop Relat Res 122:157-164
37. McGary EC, Onn A, Mills L, Heimberger A, Eton O, Thomas GW, Shtivelband M, Bar-Eli M (2004) Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo. J Invest Dermatol 122:400-405
38. McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8:3584-3591
39. Merchant MS, Woo CW, Mackall CL, Thiele CJ (2002) Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity. J Natl Cancer Inst 94:1673-1679
40. Mirra JM, Marcove RC (1974) Fibrosarcomatous dedifferentiation of primary and secondary chondrosarcoma. Review of five cases. J Bone Jt Surg Am 56:285-296
41. Mitchell AD, Ayoub K, Mangham DC, Grimer RJ, Carter SR, Tillman RM (2000) Experience in the treatment of dedifferentiated chondrosarcoma. J Bone Jt Surg Br 82:55-61
42. Mitelman F (1995) An international system for human cytogenetic nomenclature. Basel: S. Karger
43. Nawa G, Ueda T, Mori S, Yoshikawa H, Fukuda H, Ishiguro S, Funai H, Uchida A (1996) Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Int J Cancer 69:86-91
44. O'Malley DP, Opheim KE, Barry TS, Chapman DB, Emond MJ, Conrad EU, Norwood TH (2001) Chromosomal changes in a dedifferentiated chondrosarcoma: a case report and review of the literature. Cancer Genet Cytogenet 124:105-111
45. Oshiro Y, Chaturvedi V, Hayden D, Nazeer T, Johnson M, Johnston DA, Ordonez NG, Ayala AG, Czerniak B (1998) Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer 83:2324-2234
46. Ozisik YY, Meloni AM, Peier A, Altungoz O, Spanier SS, Zalupski MM, Leong SP, Sandberg AA (1994) Cytogenetic findings in 19 malignant bone tumors. Cancer 74:2268-2275
47. Sandberg AA, Bridge JA (2003) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet 143:1-31
48. Sato Y, Sasaki H, Kobayashi Y, Haruki N, Toyama T, Kondo S, Fujii Y (2003) Expression of PPAR-gamma is correlated with the clinical course of neuroblastoma. J Pediatr Surg 38:205-210
49. Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, Thomas JR (1998) Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Cancer 82:474-483
50. Schrock E, Veldman T, Padilla-Nash H, Ning Y, Spurbeck J, Jalal S, Shaffer LG, Papenhausen P, Kozma C, Phelan MC, Kjeldsen E, Schonberg SA, O'Brien P, Biesecker L, Manoir S, Ried T (1997) Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet 101:255-262
51. Seabright M (1971) A rapid banding technique for human chromosomes. Lancet 50:971-972
52. Shirahama S, Nakamura Y, Ogura K, Ishikawa H, Harima Y (1999) P53 gene analysis with Autosequencer. SRL Hokan 23:57-64
53. Simms WW, Ordonez NG, Johnston D, Ayala AG, Czerniak B (1995) p53 expression in dedifferentiated chondrosarcoma. Cancer 76:223-227
54. Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M (2003) High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 38:215-225
55. Swarts SJ, Neff JR, Johansson SL, Bridge JA (1996) Cytogenetic analysis of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet 89:49-51
56. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S (1999) DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84:114-121
57. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194-6199
58. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T (1997) Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410
59. Yagami K, Uyama Y, Yoshizawa Y, Kakuta S, Yamaguchi A, Nagumo M (2004) A human chondrogenic cell line retains multi-potency that differentiates into osteoblasts and adipocytes. Bone 34:648-655
60. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Yamamuro T (1993) p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68:1134-1139
61. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF (2002) Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 8:241-250
62. Zalupski MM, Ensley JF, Ryan J, Selvaggi S, aker LH, Wolman SR (1990) A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma. Cancer 66:1176-1182
63. Zielenska M, Bayani J, Pandita A, Toledo S, Marrano P, Andrade J, Petrilli A, Thorner P, Sorensen P, Squire JA (2001) Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma. Cancer Genet Cytogenet 130:14-21